Christopher M Verdier

Array ( [id] => 10560632 [patent_doc_number] => 09284289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Method for producing tetrahydrofuran' [patent_app_type] => utility [patent_app_number] => 14/689562 [patent_app_country] => US [patent_app_date] => 2015-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14689562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405167 [patent_doc_number] => 20150290175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'INHIBITORS OF CALCIUM-ACTIVATED CHLORIDE CHANNELS' [patent_app_type] => utility [patent_app_number] => 14/688365 [patent_app_country] => US [patent_app_date] => 2015-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29629 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11798516 [patent_doc_number] => 09539234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Treatment of circadian rhythm disorders' [patent_app_type] => utility [patent_app_number] => 14/688301 [patent_app_country] => US [patent_app_date] => 2015-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 20253 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406563 [patent_doc_number] => 20150291572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES' [patent_app_type] => utility [patent_app_number] => 14/685732 [patent_app_country] => US [patent_app_date] => 2015-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93215 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406564 [patent_doc_number] => 20150291573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'ARYL SUBSTITUTED HETEROCYCLYL SULFONES' [patent_app_type] => utility [patent_app_number] => 14/685742 [patent_app_country] => US [patent_app_date] => 2015-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63864 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11435984 [patent_doc_number] => 20170037005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'SOLID FORMS OF A PHARMACEUTICALLY ACTIVE COMPOUND' [patent_app_type] => utility [patent_app_number] => 15/303792 [patent_app_country] => US [patent_app_date] => 2015-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 3417 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11603985 [patent_doc_number] => 20170121286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'METHOD FOR PRODUCING HETEROCYCLIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 15/301525 [patent_app_country] => US [patent_app_date] => 2015-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18090 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406629 [patent_doc_number] => 20150291638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'METHODS FOR PREPARING ANTI-VIRAL NUCLEOTIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 14/681955 [patent_app_country] => US [patent_app_date] => 2015-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4012 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11395096 [patent_doc_number] => 20170015632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'METHOD FOR PRODUCING CARBOXAMIDES' [patent_app_type] => utility [patent_app_number] => 15/300805 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2711 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15300805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12086780 [patent_doc_number] => 09840500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-12 [patent_title] => 'Compounds as dual inhibitors of histone methyltransferases and DNA methyltransferases' [patent_app_type] => utility [patent_app_number] => 15/315326 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30752 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11555180 [patent_doc_number] => 20170101427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'NOVEL KLK4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/128446 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16371 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15128446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11670001 [patent_doc_number] => 20170158720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'Antimicrobial Compounds' [patent_app_type] => utility [patent_app_number] => 15/127564 [patent_app_country] => US [patent_app_date] => 2015-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25643 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12037627 [patent_doc_number] => 09815846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'TrkA kinase inhibitors, compositions and methods thereof' [patent_app_type] => utility [patent_app_number] => 15/128689 [patent_app_country] => US [patent_app_date] => 2015-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74538 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15128689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13117819 [patent_doc_number] => 10077250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-18 [patent_title] => Antifungal compound process [patent_app_type] => utility [patent_app_number] => 15/126359 [patent_app_country] => US [patent_app_date] => 2015-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18845 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11706326 [patent_doc_number] => 20170174825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN' [patent_app_type] => utility [patent_app_number] => 15/127155 [patent_app_country] => US [patent_app_date] => 2015-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8754 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10642470 [patent_doc_number] => 09359324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Process for preparing episulfide compounds' [patent_app_type] => utility [patent_app_number] => 14/656764 [patent_app_country] => US [patent_app_date] => 2015-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59331 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14656764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191533 [patent_doc_number] => 09422333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'HCV protease inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/639228 [patent_app_country] => US [patent_app_date] => 2015-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29274 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13037321 [patent_doc_number] => 10040780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Mcl-1 antagonists [patent_app_type] => utility [patent_app_number] => 15/123232 [patent_app_country] => US [patent_app_date] => 2015-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 25135 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 613 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11060841 [patent_doc_number] => 20160257803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'BIODERIVED BASED PLASTICIZERS' [patent_app_type] => utility [patent_app_number] => 14/636336 [patent_app_country] => US [patent_app_date] => 2015-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2667 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14636336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11492605 [patent_doc_number] => 20170066790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'Fluorescent Labeled Inhibitors' [patent_app_type] => utility [patent_app_number] => 15/120255 [patent_app_country] => US [patent_app_date] => 2015-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9134 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120255 [rel_patent_id] =>[rel_patent_doc_number] =>)